Dengue vaccine clinical trials in India - An opportunity to inform the global response to a re-emerging disease challenge
Int J Infect Dis
.
2019 Jul:84S:S4-S6.
doi: 10.1016/j.ijid.2019.03.016.
Epub 2019 Mar 14.
Authors
Anthony Fauci
1
,
Emily Erbelding
2
,
Stephen Whitehead
3
,
M Cristina Cassetti
4
,
F Gray Handley
5
,
Ranjan Gupta
6
Affiliations
1
National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA. Electronic address: afauci@niaid.nih.gov.
2
Division of Microbiology and Infectious Diseases, NIAID, NIH, USA. Electronic address: emily.erbelding@nih.gov.
3
Laboratory of Infectious Diseases, NIAID, NIH, USA. Electronic address: swhitehead@niaid.nih.gov.
4
Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, USA. Electronic address: ccassetti@niaid.nih.gov.
5
Office of the Director, NIAID, NIH, USA. Electronic address: handleygr@niaid.nih.gov.
6
Office of Global Research, NIAID, NIH, USA. Electronic address: guptar@niaid.nih.gov.
PMID:
30880127
DOI:
10.1016/j.ijid.2019.03.016
No abstract available
Publication types
Editorial